HHS Proposes Clinical Trial Reform to Restrict Chinese Biotech Sector Participation
The U.S. HHS proposed clinical trial reforms to limit Chinese biotech participation and boost domestic drug development.
Read More
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
HHS
Health-system and regulatory watchers brace for new FDA and HHS actions as mifepristone, vaccines, and psychedelic medicine dominate policy debate
Federal health officials prepare new FDA and HHS actions in 2024 amid debates on mifepristone, vaccines, and psychedelic medicine policies.
Read More